Drug application
SEHIPPY (VORTIOXETINE)
Drugs@FDA NDA 218328 · SEASONS BIOTECHNOLOGY (TAIZHOU) CO LTD
Key facts
| Drug name | SEHIPPY |
|---|---|
| Active ingredients | VORTIOXETINE |
| Application type | NDA |
| Application number | 218328 |
| Company | SEASONS BIOTECHNOLOGY (TAIZHOU) CO LTD |
| Dosage forms | TABLET, ORALLY DISINTEGRATING |
| Strength | 10MG |
| Marketing status | None (Tentative Approval) |
| Reference listed drug | No |
| Latest submission class | Type 2 - New Active Ingredient and Type 3 - New Dosage Form |
| Latest submission status date | Aug 17, 2026 |
At a glance
- 1–9 Submissions
- None Label versions
- None Products
- None Therapeutic equivalents
- Yes FDA letters on file
- No FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: